Get the Stockscreener App
2.675
5.64%
-0.16
BeyondSpring Inc stock is currently priced at $2.675, with a 24-hour trading volume of 41,960.
It has seen a -5.64% decreased in the last 24 hours and a +44.59% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $2.87 pivot point. If it approaches the $2.57 support level, significant changes may occur.
Previous Close:
$2.835
Open:
$2.78
24h Volume:
41,960
Market Cap:
$104.40M
Revenue:
$1.55M
Net Income/Loss:
$-27.51M
P/E Ratio:
-3.1471
EPS:
-0.85
Net Cash Flow:
$-50.09M
1W Performance:
+8.30%
1M Performance:
+44.59%
6M Performance:
+194.60%
1Y Performance:
+172.18%
1D Range:
$2.51
$2.91
52W Range:
$0.6534
$4.00
BeyondSpring Inc Stock (BYSI) Company Profile
Name
BeyondSpring Inc
Sector
Industry
Phone
646 305 6387
Address
28 Liberty Street, 39th Floor, New York, NY
BeyondSpring Inc Stock (BYSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-21 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-02-21 | Downgrade | Jefferies | Buy → Hold |
| Dec-01-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Dec-01-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-09-21 | Initiated | Robert W. Baird | Outperform |
| Aug-04-21 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Apr-05-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-11-21 | Initiated | BofA Securities | Buy |
| Dec-29-20 | Initiated | Evercore ISI | Outperform |
| Feb-07-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Nomura | Buy |
| Dec-03-19 | Initiated | William Blair | Outperform |
| Jul-10-19 | Reiterated | H.C. Wainwright | Buy |
| Apr-30-19 | Downgrade | Maxim Group | Buy → Hold |
| Oct-25-18 | Reiterated | Maxim Group | Buy |
View All
BeyondSpring Inc Stock (BYSI) Latest News
BeyondSpring (NASDAQ:BYSI) Trading Down 5.6% - MarketBeat
MarketBeat
BeyondSpring (NASDAQ:BYSI) Trading Down 5.6% - Defense World
Defense World
BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ... - GlobeNewswire
GlobeNewswire
Biotech Stock Roundup: REGN Q2 Earnings Beat, BLUE, BYSI's Updates & More - Yahoo New Zealand News
Yahoo New Zealand News
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results - br.ADVFN.com
br.ADVFN.com
Biotech Stock Roundup: REGN Q2 Earnings Beat, BLUE, BYSI's Updates & More - Yahoo New Zealand News
Yahoo New Zealand News
BeyondSpring Inc Stock (BYSI) Financials Data
BeyondSpring Inc (BYSI) Revenue 2024
BYSI reported a revenue (TTM) of $1.55 million for the quarter ending June 30, 2023.
BeyondSpring Inc (BYSI) Net Income 2024
BYSI net income (TTM) was -$27.51 million for the quarter ending June 30, 2023.
BeyondSpring Inc (BYSI) Cash Flow 2024
BYSI recorded a free cash flow (TTM) of -$50.09 million for the quarter ending December 31, 2021.
BeyondSpring Inc (BYSI) Earnings per Share 2024
BYSI earnings per share (TTM) was -$0.71 for the quarter ending June 30, 2023.
About BeyondSpring Inc
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of SCLC; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.
0.77%
1.20%
Cap:
|
Volume (24h):